^DUBAI, United Arab Emirates, Oct. 28, 2025 (GLOBE NEWSWIRE) — For
For the first time, the most complex data about the human body – the
complicated interactions between our genes, proteins and metabolites
– not be recorded as isolated signals, but as a coherent language.
Today, BioAro Inc. marks a milestone in the application of artificial
Intelligence known: the world’s first large language model (LLM) based on
unified multi-omics data sets. This “BioIntelligence(TM)”
The central technology mentioned forms the basis for the flagship platform
PanOmiQ(TM), which will be presented at the Global Health Exhibition in Riyadh. She
represents a new paradigm according to which biology is not only measurable, but
really becomes understandable.
The greatest shortcoming of modern medicine is its fragmented approach. We
drowning in data – genome snapshots, proteome profiles, metabolome evaluations
– but we lack the translator to help us understand their collective
Decipher meaning. This isolated approach makes it impossible
to understand the causes of complex diseases such as cancer and diabetes
This in turn delays healing and makes personalized therapy more difficult.
PanOmiQ(TM) breaks these silos. His Multi-Omics LLM, the one with the entire
knowledge of human biology, decodes the subtle,
nonlinear interactions that define health and disease. It
not only analyzes data points, but interprets the biological ones
message and delivers with previously unimaginable speed and clarity
Insights into causes and prognoses.
“We have moved on from just counting words to counting poetry
understand – the poetry written in the language of our own cells
said Dr. Anmol Kapoor, Founder and CEO of BioAro.?’The BioIntelligence(TM)’
is the heart of a new healthcare ecosystem. Disjointed data becomes
into a coherent dialogue between patients and their own biology
translated, making proactive, predictive health finally practical
becomes reality.”
A secure fortress for highly sensitive data
BioAro has recognized that the most confidential data – our genetic blueprint –
require the highest level of security, and therefore PanOmiQ(TM) for local
Deployment developed. The platform is based on a powerful
Fusion of FPGA acceleration and GPU computing and is used as a standalone
Information unit in the premises of a hospital or laboratory
operated.
* Your data is always safe: Given the vulnerabilities of cloud
PanOmiQ(TM) guarantees absolute data sovereignty. The platform
guarantees complete compliance with GDPR, HIPAA and local regulations
regulations and keeps the world’s most personal data safely on site
on.
* Speed where it matters: Through data processing at the edge
the platform prevents the critical delays when uploading to the
Cloud. What takes weeks with classic, non-networked tools is done
PanOmiQ(TM) thanks to parallel processing and acceleration of treatment and
Diagnosis time in just a few hours.
* Certified Accuracy: The platform has one in CAP performance testing
Accuracy of 100% is achieved, ensuring that the
groundbreaking speed with the highest reliability using
of standard guidelines.
The BioIntelligence(TM) Ecosystem: A Unified Platform for the
Healthcare
Based on the core multi-omics LLM, BioIntelligence(TM) supports a
Range of specialized and coordinated tools:
* Genelio(TM): This is where the magic of the LLM becomes personalized
Healthcare. Thanks to Genelio(TM), people can connect naturally
chat with their own genome and health data. User
can ask questions like?Why am I at increased risk for
Heart disease?” or?What effects does this genetic variant have?
on my children?” and receive clear, dialogue-oriented answers
derived directly from their individual biological profile. So
complex science becomes accessible and empowers individuals.
* PanAUM(TM): An AI-powered in silico environment for drug discovery,
which predicts and identifies molecular interactions
Therapy candidates accelerated.
* BioLIMS(TM): A next-generation, end-to-end laboratory system that
seamlessly feeds structured data into the analysis engine.
* BioELR(TM): Connects wearables, sensors and health apps to deliver AI-powered
Real-time insights for chronic disease management and the
to provide health care.
Axion(TM) – The BioIntelligence Series
To enable the operation of this ecosystem on a large scale, the
Axion(TM) series – a proprietary family of intelligent
Hardware systems designed to deliver local, FPGA-accelerated AI
Calculations with data sovereignty for on-site healthcare and research environments
are designed.
The Axion(TM) product line – Core, Ultra and Supreme – enables hospitals to
Research institutes and national health programs the seamless
Implementation of technology, each level being different
tailored to operational and data technology requirements.
Together, Axion(TM) and PanOmiQ(TM) define speed, data sovereignty and
Scalability new and ensure that the medicine of the future is safe everywhere
and can be used intelligently.
?For the United Arab Emirates and the entire Gulf region, both
This is to rely on technological pioneering as well as data sovereignty
a groundbreaking solution,” said Bader Al-Marzooqi, a leading investor in the
Healthcare technology sector from the UAE.?BioAro doesn’t just import
Technology, but delivers a sovereign solution that works with our national
Vision of a safe, innovative and proactive future in healthcare
harmony. It empowers and protects our medical professionals
at the same time the data of our citizens.”
Presentation at the Global Health Exhibition – Riyadh
At the Global Health Exhibition in Riyadh, BioAro will demonstrate its performance
its ecosystem through a live conversation with Genelio(TM) and a
Demonstrate real-time multi-omics analysis with PanOmiQ(TM).
“We’re not just launching a product, we’re creating a new movement
from – away from reactive conjectures towards more proactive, intelligent ones
Health,” said Dr. Kapoor.?The future of medicine speaks the language of
life itself, and we are proud to give it a voice in Riyadh.”
About BioAro Inc.
BioAro Inc. is a Canada-based software and
Biotechnology company that promotes the development of intelligent health
inclusive data sovereignty. Its mission is to connect
Biology and data science through The Bio Intelligence(TM) to fill the gap
between complex molecular information and actionable, personalized one
health findings.
Media contact:
Mohini
Email: [email protected]
Phone: +1-403-250-2221
For more information please visit: www.PanOmiQ.com
(https://www.panomiq.com/) | www.BioAro.com (https://www.bioaro.com/)
Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/83d816d2-5608-4ef8-a36f-
bf9d55cda525
https://www.globenewswire.com/NewsRoom/AttachmentNg/18aa3fb2-b13e-4a25-a7cb-
4557cba39e89
°